Vneuron Risk and Compliance Voted Best Anti-Money Laundering Compliance Solution Provider in Waters Rankings Awards 2023
17.7.2023 10:00:00 EEST | Business Wire | Press release
Vneuron Risk & Compliance is honored to announce its selection as the "Best AML Compliance Solution Provider'' for 2023 by Waters Rankings Readers and its esteemed clientele. This prestigious recognition stems from the publisher's annual voting, solidifying Vneuron's industry standing.
The twenty-first edition of the Waters Rankings awards competition showcased 35 awards across five categories, including trading services, trading tools, data management, compliance risk management, and infrastructure/connectivity. Each award acknowledges the outstanding global excellence of the ultimate winner.
In the category of Best AML Compliance Solution Provider, Vneuron Risk & Compliance has emerged victorious among 17 nominated global providers, a remarkable feat considering the previous dominance of legacy vendors in this category. This accomplishment underscores Vneuron's dedication to bringing the most advanced technologies for efficiently combating money laundering and terrorism financing on a global scale.
Vneuron has garnered significant recognition in the market following its successful integration of comprehensive regulatory coverage with advanced technologies. This unique approach allows Vneuron to offer automated Know Your Customer (KYC) procedures and screening workflows, along with real-time transaction filtering and AI-powered monitoring. Furthermore, Vneuron provides case management and dynamic investigation capabilities, reinforcing its comprehensive suite of services.
Furthermore, Vneuron addresses the challenge of maintaining compliance while enhancing the customer experience. User-friendly digital portals and self-onboarding tools engage customers throughout the onboarding and review processes, facilitating efficient fulfillment of KYC obligations. Additionally, its process automation engine, integrated into the customer lifecycle platform and KYC component, ensures swift approvals and investigations.
To learn more about Vneuron’s solutions, visit www.vneuron.com
About the Company:
Vneuron, an innovative Anti-Money Laundering (AML) technology provider, designs and implements robust regulatory solutions for over 200 financial institutions across Europe, the Middle East, and Africa. With its headquarters in France, Vneuron is committed to offering customizable solutions tailored to the needs of modern banks as well as non-banking financial institutions, encompassing insurance, capital markets, lending, and FinTech sectors.
About Waters Rankings:
For over two decades, Waters Rankings has provided technology and data insights for the finance industry. With researchers in London, New York, and Hong Kong, the magazine ensures global exposure to financial markets. Through in-depth investigations, readers gain a comprehensive understanding of technology providers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230714900920/en/
Contact information
For media inquiries, please contact:
Ameni Naimi
press@vneuron.com
For Other inquiries
hello@vneuron.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IFF Secures First Heart Health Claim for Soy Protein in Australia and New Zealand31.3.2026 17:00:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and health & biosciences announced today that a new heart health claim for isolated soy protein has been accepted by the Food Standards Australia New Zealand (FSANZ). The approval enables food and beverage manufacturers in Australia and New Zealand to link soy protein consumption with healthy blood cholesterol levels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330523416/en/ First heart health claim approved for soy protein in Australia and New Zealand. “For decades, IFF has invested in the science behind soy protein and its role in supporting cardiovascular health,” said Tony Andrew, vice president of protein solutions for IFF Food Ingredients. “This approved claim validates years of rigorous research and collaboration. With our deep expertise in ingredient science, application and scale, we are well-positioned to help our customers translate th
Andersen Consulting Strengthens Capabilities with Addition of Lukkap31.3.2026 16:30:00 EEST | Press release
Andersen Consulting adds collaborating firm Lukkap, a consultancy focused on experience-driven capabilities aligned with clients’ evolving people, customer, and digital transformation needs. Founded in 2009 and headquartered in Spain, Lukkap delivers integrated solutions that help organizations transform how they serve customers, engage employees, and unlock value through behavioral insights and data analytics. The firm’s multidisciplinary approach spans customer journey redesign, high-impact employee experience programs, talent and leadership development, predictive analytics, and comprehensive outplacement and transition services. Lukkap works across sectors — including healthcare, pharmaceutical, consumer goods, retail, finance, and banking — to build human-centered strategies that drive measurable business results. “By combining our experience-led methodology with Andersen Consulting’s global platform, we can accelerate the way organizations approach customer experience,” said Albe
Sub-Q Bionics Closes $1.5M Pre-Seed Round to Advance Next-Generation Solution for Lymphedema Care31.3.2026 16:26:00 EEST | Press release
Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5 million pre-seed funding round. The round includes investment from Mayo Clinic and Yeda, the technology transfer company of the Weizmann Institute of Science, as well as several private investors. The Israel Innovation Authority also provided matching funds. The funding will enable Sub-Q Bionics to continue to develop its novel bionic lymph node technology designed to transform how lymphedema is managed, based on scientific innovations from the Weizmann Institute and Shamir Medical Center. The system aims to provide a solution to manage fluid with a subcutaneous implant that will allow patients freedom of movement, automatic fluid management and reduction of symptoms such as pain and swelling. Lymphedema affects millions of patients worldwide, especially breast cancer survivors, and remains significantly under
HTEC Achieves SOC 2 Type II Attestation, Reinforcing Commitment to Client Trust31.3.2026 16:25:00 EEST | Press release
HTECtoday announced that it has successfully achieved a SOC 2 Type II attestation, audited by Deloitte, demonstrating the company’s commitment to maintaining high standards in security, availability, and confidentiality. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260331132225/en/ HTEC today announced that it has successfully achieved a SOC 2 Type II attestation, audited by Deloitte, demonstrating the company’s commitment to maintaining high standards in security, availability, and confidentiality. For clients, this means working with a technology partner whose practices are standardized, consistently executed, and independently verified over time. It reflects a level of operational maturity where security, reliability, and data protection are built into every engagement. Achieving this standard required coordinated effort across the entire organization. Compliance, engineering, delivery, security, IT, legal, and people t
Impartner Redefines Partner Marketing Automation with Full Automation, AdTech and AI to Drive Measurable Revenue31.3.2026 16:00:00 EEST | Press release
Impartner, the world’s leading partner revenue orchestration platform, today announced a major advancement that unifies partner marketing automation within the platform, powered by full automation, AdTech and AI to turn partner marketing into measurable revenue. As partner ecosystems expand across regions, marketplaces and multi-tier models, marketing execution has often remained fragmented. Impartner eliminates those gaps by unifying recruitment, enablement, campaign automation and performance tracking within a single operational system, making partner demand generation and marketing fully operational, measurable, and scalable across all partner interactions. “What makes partner marketing successful is not content distribution, it’s execution, scale and measurable pipeline and revenue,” said Emile van de Klok, Senior Director of Channel Marketing Solutions at Impartner. “By redefining partner marketing automation and embedding it directly into our revenue orchestration platform, we en
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom